Scilex reports preliminary ZTlido Feb 2023 gross sales up ~70% YoY

Scilex Holding Co

2022-FY EPS reported -$0.17 revenue$38,034,000

ZTlido gross sales for Feb 2023 estimated at $8.6M-$8.8M, up 68%-72% from $5.1M in Feb 2022.
Year-to-date Feb 2023 gross sales $16.7M-$17.3M, up 62%-68% from $10.3M in prior year.
Net sales for Feb 2023 estimated at $3.3M-$3.5M, up 65%-75% from $2.0M in Feb 2022.
Year-to-date Feb 2023 net sales $6.6M-$7.0M, up 61%-70% from $4.1M in prior year.
Company notes Q1 sales typically low due to managed healthcare plan deductibles.

item 2.02 item 9.01

Key facts

Extracted from this filing and checked against the source text.

Earnings Releases SEC 8-K Item 2.02 confidence 0.9

Scilex Holding Co reported the one month ended February 28, 2023 results: revenue ZTlido gross sales for February 2023 were in the range of $8.6 million to $8.8 million.

Period: the one month ended February 28, 2023
Revenue: ZTlido gross sales for February 2023 were in the range of $8.6 million to $8.8 million
Result: preliminary results

Exact text from the filing

Scilex Holding Company (the "Company") is providing certain preliminary unaudited financial results for the one month ended February 28, 2023, and as of February 28, 2023, based on currently available information.

View on SEC.gov

8 earnings releases filed in the last 30 days. Browse all earnings releases →

Scilex Holding Co filing history →

Source: SEC EDGAR

accession 0001193125-23-055030

view filing index on sec.gov

view primary document

Machine-readable: JSON · Markdown · Plain text

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.